Bliss Gvs Pharma Ltd

BLISSGVS NSE Healthcare Pharmaceuticals
₹720.95
+2.93%
Delayed · cached 15 min

Fair value analysis

BLISSGVS
Bliss Gvs Pharma Ltd
Healthcare›Pharmaceuticals
₹700.45
Close used for this calculation
₹290.88Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
53/100
Profitability21/25
Returns5/25
Balance Sheet21/25
Efficiency6/25
Growth12/25
Good
Quality radar
53Prof.21/25Ret.5/25Eff.6/25B.Sht21/25Growth12/25

Consensus fair value

₹290.88
Above FV
▼ -58.5% against the close used
Model range ₹152.34 – ₹549.89
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹152.34Fair value₹290.88Bull₹549.89
FairClose
52-week traded range
52W low ₹127.9052W high ₹722.30

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Bliss Gvs Pharma Ltd closed at ₹700.45, 140.8% above the consensus fair value of ₹290.88 drawn from 9 valuation models.

Financial DNA score 53/100 — Good. P/E of 55.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹152.34
-78.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹178.79
-74.5%
√(22.5 × EPS × BVPS)
EPS=12.21, BVPS=116.35 · outside Graham range (P/E 55.7, P/B 6) — asset-light, treat as a rough floor
Graham Formula
₹549.89
-21.5%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹435.90
-37.8%
EPS × 35.7x (sector P/E)
EPS=12.21, Sector P/E=35.7x
Peter Lynch (PEG)
₹262.52
-62.5%
EPS × Growth% (PEG = 1 is fair)
EPS=12.21, g=21.5%
EV/EBITDA
₹328.57
-53.1%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=2.01B
Book Value (P/B)
₹168.71
-75.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=116.35, ROE=11.8%, g=6%, r=10%
Reverse DCF
₹700.45
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 21.4% | Historical: 21.5%
Margin of Safety
₹246.92
-64.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=329.23, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.